| Authors: |
Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Innovation and Service Unit for Bioinformatics and Precision Medicine, DKFZ, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de., Kreutzfeldt S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Roth B; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany., Glocker K; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Medical Genetics Center, Munich, Germany., Schoop J; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany., Oeser L; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany., Hausmann S; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany., Koch C; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany., Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany., Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany., Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany., Fröhlich M; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany., Heilig CE; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Teleanu MV; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Lipka DB; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Kerle IA; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany., Baude-Müller A; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Beck K; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Heining C; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany., Glimm H; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany., Ückert F; Institute for Applied Medical Informatics, Medical Center Hamburg-Eppendorf, Hamburg, Germany., Knurr A; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany., Fröhling S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de., Horak P; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de. |
